Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate the PK/PD and Safety of KL0011034 Injection in Healthy Non-Elderly and Elderly Trial Participants
Sponsor: Hunan Kelun Pharmaceutical Co., Ltd.
Summary
To evaluate the pharmacokinetic characteristics of a single intravenous injection of KL0011034 injection in healthy non-elderly and elderly trial participants. To evaluate the pharmacodynamics and safety of a single intravenous injection of KL0011034 injection in healthy non-elderly and elderly trial participants.
Official title: A Single-Dose Study to Evaluate the Pharmacokinetics/Pharmacodynamics and Safety of KL0011034 Injection in Healthy Non-Elderly and Elderly Trial Participants
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-11-20
Completion Date
2026-11-30
Last Updated
2026-11-03
Healthy Volunteers
Yes
Conditions
Interventions
KL0011034 injection
Intravenous injection, single dose
Locations (1)
The Third XIANGYA Hospital of Central South University
Changsha, Hunan, China